Sava

Wearable biosensors / glucose monitoring, London

Imperial spinout building painless microsensor wearables for continuous glucose and biomarker monitoring. It raised €32.1m in its Series B in October 2026. We can't read its job board yet.

Not found on the Home Office register of licensed visa sponsors.

Open roles over time

We can't read this company's job board yet.

Hiring momentum

Roles per week

Not tracked yet.

In the news

All 91 stories